Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (11240)	11/16/1997 4:22:00 PM
From: Andreas Helke	Respond to of 32384

I did not manage to sell anything near the top. I sold about 10% of my Ligand shares on the way down for $15.75 and a few days later I replaced them with the same number of Ligand warrants for $8.625. If LGNDW drops below $5 I will get problems with the margin requirements of my Datek account. But I think I will prefer to sell something else in that case or move more money into that account. I don't think that any Ligand shareholder cared very much if Ligand made its deal with J&J or Ely Lilly. Both Pharmas are big in the diabetes market. Andreas